Cryptic mutations of PLC family members in brain disorders: recent discoveries and a deep-learning-based approach.

Journal: Brain : a journal of neurology
Published Date:

Abstract

Phospholipase C (PLC) is an essential isozyme involved in the phosphoinositide signalling pathway, which maintains cellular homeostasis. Gain- and loss-of-function mutations in PLC affect enzymatic activity and are therefore associated with several disorders. Alternative splicing variants of PLC can interfere with complex signalling networks associated with oncogenic transformation and other diseases, including brain disorders. Cells and tissues with various mutations in PLC contribute different phosphoinositide signalling pathways and disease progression, however, identifying cryptic mutations in PLC remains challenging. Herein, we review both the mechanisms underlying PLC regulation of the phosphoinositide signalling pathway and the genetic variation of PLC in several brain disorders. In addition, we discuss the present challenges associated with the potential of deep-learning-based analysis for the identification of PLC mutations in brain disorders.

Authors

  • Key-Hwan Lim
    Neurodegenerative Disease Research Group, 41062 Daegu, Republic of Korea.
  • Sumin Yang
    Neurodegenerative Disease Research Group, 41062 Daegu, Republic of Korea.
  • Sung-Hyun Kim
    Neurodegenerative Disease Research Group, 41062 Daegu, Republic of Korea.
  • Euiseong Ko
    Department of Computer Science at the University of Nevada, Las Vegas, NV, USA.
  • Mingon Kang
    Department of Computer Science, Kennesaw State University, Marietta, 30060, Georgia, USA.
  • Jae-Yeol Joo
    Neurodegenerative Disease Research Group, 41062 Daegu, Republic of Korea; joojy@kbri.re.kr.